4.8 News Item

A Case for a Human Immuno-Peptidome Project Consortium

期刊

IMMUNITY
卷 47, 期 2, 页码 203-208

出版社

CELL PRESS
DOI: 10.1016/j.immuni.2017.07.010

关键词

-

资金

  1. HUPO
  2. Ludwig Cancer Research
  3. Swiss National Science Foundation
  4. SystemsX
  5. Swiss Cancer League
  6. eLife Scientific Publications
  7. Genentech
  8. Novartis
  9. Roche
  10. Biognosys
  11. Merck
  12. ThermoFisher Scientific
  13. EC HOR2020 project TBVAC2020 [2-73838-14]

向作者/读者索取更多资源

A multidisciplinary group of researchers gathered at the Honggerberg Campus at ETH Zurich, Switzerland, for the first meeting on the Human Immuno-Peptidome Project (https://hupo.org/human-immunopeptidome-project/). The long-term goal of this project is to map the entire repertoire of peptides presented by human leukocyte antigen molecules using mass spectrometry technologies, and make its robust analysis accessible to any immunologist. Here we outline the specific challenges identified toward this goal, and within this framework, describe the structure of a multipronged program aimed at addressing these challenges and implementing solutions at a community-wide level. Pillars of that program are: (1) method and technology development, (2) standardization, (3) effective data sharing, and (4) education. If successful, this community-driven endeavor might provide a roadmap toward new paradigms in immunology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据